Serum Level of Antibodies (IgG, IgM) Against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in Children Dermatologically Exposed to Coal Tar

Acta Medica (Hradec Kralove). 2017;60(1):27-31. doi: 10.14712/18059694.2017.46. Epub 2017 May 3.

Abstract

Crude coal tar (CCT) contains polycyclic aromatic hydrocarbons (PAHs). Benzo[a]pyrene (BaP) is metabolized into a highly reactive metabolite benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE) that is able to bind to DNA and creates BPDE-DNA adducts. Adducted DNA becomes immunogenic and induces immune response by production of antibodies against BPDE-DNA adducts (Ab-BPDE-DNA). Circulating Ab-BPDE-DNA was proposed as potential biomarker of genotoxic exposure to BaP (PAHs). Goeckerman therapy (GT) of psoriasis uses dermal application of CCT ointment (PAHs). In presented study (children with psoriasis treated by GT; n = 19) the therapy significantly increased the level of Ab-BPDE-DNA (EI = 0.29/0.19-0.34 vs. 0.31/0.25-0.40; median/lower-upper quartile; p < 0.01). The results support the idea of Ab-BPDE-DNA level as a possible tentative indicator of exposure, effects and susceptibility of the organism to the exposure of BaP (PAHs).

Keywords: BPDE-DNA adducts; antibodies; children; coal tar; goeckerman therapy; polycyclic aromatic hydrocarbons; psoriasis.

MeSH terms

  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / analysis*
  • Child
  • Child, Preschool
  • Coal Tar / adverse effects*
  • Coal Tar / therapeutic use
  • DNA Adducts / blood*
  • DNA Adducts / drug effects
  • DNA Damage / drug effects
  • Humans
  • Keratolytic Agents / administration & dosage*
  • Keratolytic Agents / therapeutic use
  • Psoriasis / drug therapy*

Substances

  • DNA Adducts
  • Keratolytic Agents
  • 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
  • Coal Tar